The {pharmaceutical industry is increasingly exploring novel treatment strategies for obesity , and the introduction of semaglutide 10mg doses represents the development . Healthcare providers are now consider the likely benefits and risks associated with this increased strength version , especially in relation to existing lower-dose semaglutide me